Mutation in a previously overlooked part of DNA is likely to be a common cause of intellectual disability

Publicly released:
International
Image by Thomas from Pixabay
Image by Thomas from Pixabay

Mutations in a small but previously overlooked gene, called RNU4-2, have been found to cause developmental disorders and may provide a genetic diagnosis for thousands of people with intellectual disabilities, according to international research. Most genes linked to intellectual disabilities code for specific proteins, but this newly identified gene is in a non-coding part of DNA and instead of coding for a protein it helps make a part of a cell's machinery called a spliceosome. The study found that mutations in this gene may be among the most common genetic causes of neurodevelopmental disorders. The authors say that thanks to this study, tens of thousands of families will now be able to find a clear genetic diagnosis for conditions affecting their family members.

Media release

From: Springer Nature

1.  Health: Mutations to a non-coding gene associated with intellectual disability *PRESS BRIEFING*

Rare mutations to RNU4-2 — a gene that encodes a critical component of an RNA–protein complex called a spliceosome — may be a contributing factor in a greater proportion of clinically diagnosed intellectual disability cases than any other non-sex-related gene identified so far, reports a large genetic study in Nature Medicine. These newly identified mutations have the potential to inform clinical diagnostic and therapeutic approaches for certain neurodevelopmental disorders.

Intellectual disability (ID) is a neurodevelopmental disorder characterized by difficulties in intellectual functioning, as well as in social and practical skills. Although 1,427 genes are linked to ID, most ID cases remain unexplained after genetic testing. All but 9 of the 1,427 known genes are protein-coding, in part because the largest genetic studies of ID have used whole-exome sequencing, which typically omits non-protein-coding genes. Spliceosomes are molecular machines that remove introns (non-coding sections) from pre-mRNA, joining the remaining exons (coding sections) to form mature mRNA.

Daniel Greene, Ernest Turro and colleagues conducted a genetic association analysis using whole-genome sequencing data from 77,539 participants enrolled in the 100,000 Genomes Project, a large genetic database created to help researchers identify mutations responsible for diseases with unknown causes. The dataset included 5,529 people clinically diagnosed with ID. The authors identified rare new mutations in the non-protein-coding gene RNU4-2 — which encodes a spliceosome component — that were strongly associated with the potential to develop ID. These associations were further validated in three large and independent genetic databases, and the authors identified 73 affected cases across all four collections.

The authors emphasize that the precise mechanism underlying these mutations remains unclear and needs to be investigated in further studies. However, these results provide a potential genetic cause for many clinically diagnosed neurodevelopmental disorders with previously unknown causes.

***

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research Springer Nature, Web page Please link to the article in online versions of your report (the URL will go live after the embargo ends).
Journal/
conference:
Nature Medicine
Research:Paper
Organisation/s: Icahn School of Medicine at Mount Sinai, USA
Funder: The National Genomic Research Library is funded by the National 191 Institute for Health Research and NHS England. The Wellcome Trust, Cancer Research UK and 192 the Medical Research Council have also funded research infrastructure. We thank NBR 193 volunteers for their participation, and gratefully acknowledge NBR centers, NHS Trusts and staff 194 for their contribution. We thank the National Institute for Health and Care Research, NHS Blood 195 and Transplant, and Health Data Research UK as part of the Digital Innovation Hub 196 Programme. The views expressed are those of the author(s) and not necessarily those of the 197 NHS, the NIHR or the Department of Health and Social Care. K.F. was supported by Katholieke 198 Universiteit (KU) Leuven Special Research Fund (BOF) (C14/19/096 and C14/23/121) and 199 Research Foundation – Flanders (G072921N). D.G. and E.T. were supported by NIH awards 200 R01HL161365 and R03HD111492 and E.T. was further supported by the Lowy Foundation 201 USA.
Media Contact/s
Contact details are only visible to registered journalists.